IFNG and neoplasm: Thus, IFN-γ treatment can boost the activity of macrophages and/or dendritic cells in securing, in conjunction with γ-inulin potentiated complement activation, immune recognition of PDT-treated tumours and augment immune rejection of these lesions with resultant prevention of tumour recurrence.